Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to 0.04.

  • Agios Pharmaceuticals' Asset Utilization Ratio rose 9062.84% to 0.04 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04, marking a year-over-year increase of 9062.84%. This contributed to the annual value of 0.04 for FY2025, which is 3002.36% up from last year.
  • Agios Pharmaceuticals' Asset Utilization Ratio amounted to 0.04 in Q4 2025, which was up 9062.84% from 0.03 recorded in Q3 2025.
  • Agios Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.07 during Q1 2021, with a 5-year trough of 0.0 in Q1 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.03 (2024), whereas its average is 0.03.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 9913.67% in 2022, then surged by 255253.37% in 2023.
  • Over the past 5 years, Agios Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then plummeted by 54.34% to 0.01 in 2022, then skyrocketed by 134.35% to 0.03 in 2023, then dropped by 23.42% to 0.02 in 2024, then skyrocketed by 90.63% to 0.04 in 2025.
  • Its last three reported values are 0.04 in Q4 2025, 0.03 for Q3 2025, and 0.03 during Q2 2025.